New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40 mg - film coated tablet - 40 mg - active: atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80 mg - film coated tablet - 80 mg - active: atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 1000mg - film coated tablet - 1000 mg - active: levetiracetam 1000mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry white 85f18422 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 250mg - film coated tablet - 250 mg - active: levetiracetam 250mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry blue 85f20694 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 500mg - film coated tablet - 500 mg - active: levetiracetam 500mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry yellow 85f32004 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 750mg - film coated tablet - 750 mg - active: levetiracetam 750mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry orange 85f23452 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - solifenacin succinate 10mg - film coated tablet - 10 mg - active: solifenacin succinate 10mg excipient: hypromellose lactose monohydrate magnesium stearate maize starch opadry pink 03f540032

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - solifenacin succinate 5mg - film coated tablet - 5 mg - active: solifenacin succinate 5mg excipient: hypromellose lactose monohydrate magnesium stearate maize starch opadry yellow 03f520046 - solifenacin film-coated tablets are indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent micturition, and/or urge incontinence.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - aconitum napellus; atropa belladonna; chloroform - liniment - active: aconitum napellus atropa belladonna chloroform

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - cetostearyl alcohol; chlorocresol; emulsifying wax; liquid paraffin; white soft paraffin - topical cream - active: cetostearyl alcohol chlorocresol emulsifying wax liquid paraffin white soft paraffin